Index – Foreign – Presumably there were problems with the vaccines, but they were allowed

The Pfizer-BioNTech and Moderna vaccines were still being tested and both had problems when they were already licensed in the European Union. This shocking news came from Le Monde in France, which managed to obtain documents from the European Medicines Agency (EMA).

Another twist in the case is that confidential documents stolen last December, most likely by Russian hackers, dark weband landed. From here, an international team of journalists downloaded the scientific evaluation of the drugs. According to them, the EMA raised three main objections to the Pfizer-BioNTech vaccine:

• some production sites have not yet had a chance to be inspected,
• data was lacking on vaccines intended for mass production, i.e. marketed,
• the quality of the vaccines sent for testing differs from the quality of the vaccines that the pharmaceutical company mass-produced.

The latter was supposedly of particular concern to the granting authority, as it suspected that

News airline Mérce knows that pressure has nonetheless been put on the European Medicines Agency to approve the Pfizer vaccine.

Several of the letters received suggest that EU agencies have lobbied the EMA to allow the Pfizer vaccine in EU member states as soon as possible, after similar authorities in the US and the UK allowed the free use of the vaccine.

– write in your article. The spice of the matter is that the EMA, after learning of the leak, claimed that the data had been tampered with, while the documents now released reflected the problems that had arisen.

The truth is that vaccine maker Pfizer-BioNTech had trouble switching to mass production. Already in December, it seemed that it could not produce as many vaccines as it had contracted. And at the end of last week, he was forced to admit that he could not deliver the requested amounts to the European Union, forcing six member states to redesign their vaccination schedules.